2022
DOI: 10.1371/journal.pone.0267856
|View full text |Cite
|
Sign up to set email alerts
|

Association between time to emergency neurosurgery and clinical outcomes for spontaneous hemorrhagic stroke: A nationwide observational study

Abstract: Objective Spontaneous hemorrhagic stroke is a devastating disease with high mortality and grave neurological outcomes worldwide. This study aimed to evaluate the association between the elapsed time from emergency department (ED) visit to emergency neurosurgery and clinical outcomes in patients with spontaneous hemorrhagic stroke. Methods A nationwide cross-sectional study was conducted using the nationwide emergency database in Korea. Spontaneous hemorrhagic stroke patients who received neurosurgery within … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 27 publications
2
2
0
Order By: Relevance
“…In our study, we have shown that MSC secretome, when administered intravenously within 1 h after modeling the intracerebral hemorrhage, provides a better outcome in the experimental animals with the least severity of neurological disorders and the least brain lesion volume. This correlates with the literature data available, the so-called stroke golden hour-60 min after a stroke when the effectiveness of neuroprotection is maximum [51,52]. With an increase in the time interval between the modeling of intracerebral hemorrhage and intravenous administration of MSC secretome (from 1 to 6 h), the effectiveness of neuroprotection decreased, which correlated with literature data [49][50][51][52] and manifested in the worse neurological outcome and larger lesion volume in the brain tissue.…”
Section: Discussionsupporting
confidence: 85%
See 1 more Smart Citation
“…In our study, we have shown that MSC secretome, when administered intravenously within 1 h after modeling the intracerebral hemorrhage, provides a better outcome in the experimental animals with the least severity of neurological disorders and the least brain lesion volume. This correlates with the literature data available, the so-called stroke golden hour-60 min after a stroke when the effectiveness of neuroprotection is maximum [51,52]. With an increase in the time interval between the modeling of intracerebral hemorrhage and intravenous administration of MSC secretome (from 1 to 6 h), the effectiveness of neuroprotection decreased, which correlated with literature data [49][50][51][52] and manifested in the worse neurological outcome and larger lesion volume in the brain tissue.…”
Section: Discussionsupporting
confidence: 85%
“…This correlates with the literature data available, the so-called stroke golden hour-60 min after a stroke when the effectiveness of neuroprotection is maximum [51,52]. With an increase in the time interval between the modeling of intracerebral hemorrhage and intravenous administration of MSC secretome (from 1 to 6 h), the effectiveness of neuroprotection decreased, which correlated with literature data [49][50][51][52] and manifested in the worse neurological outcome and larger lesion volume in the brain tissue.…”
Section: Discussionsupporting
confidence: 85%
“…However, the dura-tion from symptom onset to ED visit increased with the increase in age. Earlier admission and early neurosurgical intervention were associated with favorable outcomes in acute ischemic stroke and spontaneous hemorrhagic stroke [13,14]. Several stroke recognition systems and educational programs have been developed and implemented in prehospital settings [15].…”
Section: Insights and Challengesmentioning
confidence: 99%
“…The mantra “time is brain” is also certainly true for ischemic stroke, but it may also be applicable to intracerebral hemorrhage given that hematoma expansion occurs in over 70% of patients during the first 24 hours and may lead to increased morbidity and mortality 6,7 . Clinically significant hematoma expansion typically occurs early in the patient’s clinical course 8 .…”
Section: Introductionmentioning
confidence: 99%